Variant report
Variant | esv3438547 |
---|---|
Chromosome Location | chr3:195720855-195726353 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:235)
- CpG islands (count:183)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr3:195723014-195723259 | GM12878 | blood: | n/a | chr3:195723080-195723089 |
2 | BCL11A | chr3:195722372-195722606 | GM12878 | blood: | n/a | n/a |
3 | CBX3 | chr3:195721219-195721517 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr3:195721166-195721620 | K562 | blood: | n/a | n/a |
5 | CTCF | chr3:195721205-195721655 | K562 | blood: | n/a | n/a |
6 | CTCF | chr3:195721356-195721525 | Hela-S3 | cervix: | n/a | n/a |
7 | CTCF | chr3:195721260-195721410 | WI-38 | lung: | n/a | n/a |
8 | CTCF | chr3:195721760-195721910 | AoAF | blood vessel: | n/a | n/a |
9 | CTCF | chr3:195721250-195721595 | GM12878 | blood: | n/a | n/a |
10 | CTCF | chr3:195721260-195721410 | AG09319 | gingival: | n/a | n/a |
11 | CTCF | chr3:195721260-195721410 | WERI-Rb-1 | eye: | n/a | n/a |
12 | CTCF | chr3:195721345-195721557 | GM19238 | blood: | n/a | n/a |
13 | CTCF | chr3:195721260-195721410 | GM12874 | blood: | n/a | n/a |
14 | CTCF | chr3:195721340-195721490 | GM12867 | blood: | n/a | n/a |
15 | CTCF | chr3:195721260-195721410 | HRE | kidney: | n/a | n/a |
16 | CTCF | chr3:195721720-195721870 | HCPEpiC | choroid plexus: | n/a | n/a |
17 | CTCF | chr3:195721275-195721547 | A549 | lung: | n/a | n/a |
18 | CTCF | chr3:195722140-195722290 | GM12866 | blood: | n/a | n/a |
19 | CTCF | chr3:195721330-195721519 | GM10248 | blood: | n/a | n/a |
20 | CTCF | chr3:195722080-195722230 | HMF | breast: | n/a | n/a |
21 | CTCF | chr3:195721340-195721490 | BE2_C | brain: | n/a | n/a |
22 | CTCF | chr3:195721280-195721430 | GM12872 | blood: | n/a | n/a |
23 | CTCF | chr3:195721720-195721870 | WI-38 | lung: | n/a | n/a |
24 | CTCF | chr3:195721340-195721490 | GM12868 | blood: | n/a | n/a |
25 | CTCF | chr3:195721300-195721450 | HFF-Myc | foreskin: | n/a | n/a |
26 | CTCF | chr3:195721313-195721565 | A549 | lung: | n/a | n/a |
27 | CTCF | chr3:195721340-195721490 | GM12869 | blood: | n/a | n/a |
28 | CTCF | chr3:195721280-195721430 | HRPEpiC | eye: | n/a | n/a |
29 | CTCF | chr3:195721364-195721549 | MCF-7 | breast: | n/a | n/a |
30 | CTCF | chr3:195721260-195721410 | K562 | blood: | n/a | n/a |
31 | CTCF | chr3:195721076-195721660 | K562 | blood: | n/a | n/a |
32 | CTCF | chr3:195721320-195721470 | HPAF | blood vessel: | n/a | n/a |
33 | CTCF | chr3:195721382-195721522 | MCF-7 | breast: | n/a | n/a |
34 | CTCF | chr3:195721360-195721510 | GM12871 | blood: | n/a | n/a |
35 | CTCF | chr3:195721340-195721490 | GM12865 | blood: | n/a | n/a |
36 | CTCF | chr3:195721324-195721562 | GM12878 | blood: | n/a | n/a |
37 | CTCF | chr3:195721257-195721571 | Gliobla | brain: | n/a | n/a |
38 | CTCF | chr3:195721280-195721430 | HFF | foreskin: | n/a | n/a |
39 | CTCF | chr3:195721300-195721450 | GM12871 | blood: | n/a | n/a |
40 | CTCF | chr3:195721384-195721497 | GM19239 | blood: | n/a | n/a |
41 | CTCF | chr3:195721280-195721430 | A549 | lung: | n/a | n/a |
42 | CTCF | chr3:195721260-195721410 | GM12864 | blood: | n/a | n/a |
43 | CTCF | chr3:195721352-195721514 | MCF-7 | breast: | n/a | n/a |
44 | CTCF | chr3:195721260-195721410 | AG10803 | skin: | n/a | n/a |
45 | CTCF | chr3:195721300-195721450 | HRPEpiC | eye: | n/a | n/a |
46 | CTCF | chr3:195722080-195722230 | HCPEpiC | choroid plexus: | n/a | n/a |
47 | CTCF | chr3:195721320-195721470 | HCPEpiC | choroid plexus: | n/a | n/a |
48 | CTCF | chr3:195721348-195721507 | MCF-7 | breast: | n/a | n/a |
49 | CTCF | chr3:195721320-195721470 | GM12865 | blood: | n/a | n/a |
50 | CTCF | chr3:195721340-195721490 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195724371-195724421 | T-47D | breast: | n/a |
2 | chr3:195724371-195724421 | AG04449 | skin: | fetal |
3 | chr3:195723614-195723664 | Caco-2 | colon: | n/a |
4 | chr3:195723614-195723664 | HRPEpiC | eye: | n/a |
5 | chr3:195723614-195723664 | BE2_C | brain: | n/a |
6 | chr3:195723614-195723664 | ProgFib | skin: | n/a |
7 | chr3:195724401-195724451 | NHBE | bronchial: | n/a |
8 | chr3:195723614-195723664 | HCPEpiC | choroid plexus: | n/a |
9 | chr3:195724401-195724451 | Jurkat | blood: | n/a |
10 | chr3:195724371-195724421 | H1-hESC | embryonic stem cell: | embryo |
11 | chr3:195724371-195724421 | Hepatocyte | liver: | n/a |
12 | chr3:195723614-195723664 | HAEpiC | amniotic membrane: | n/a |
13 | chr3:195724401-195724451 | PrEC | prostate: | n/a |
14 | chr3:195724401-195724451 | SK-N-SH_RA | brain: | n/a |
15 | chr3:195724401-195724451 | AG10803 | skin: | n/a |
16 | chr3:195723614-195723664 | SK-N-SH | brain: | n/a |
17 | chr3:195723614-195723664 | PANC-1 | pancreas: | n/a |
18 | chr3:195724401-195724451 | MCF10A-Er-Src | breast: | n/a |
19 | chr3:195724401-195724451 | HCF | heart: | n/a |
20 | chr3:195724401-195724451 | HCPEpiC | choroid plexus: | n/a |
21 | chr3:195724401-195724451 | HCM | heart: | n/a |
22 | chr3:195724401-195724451 | HUVEC | blood vessel: | n/a |
23 | chr3:195724401-195724451 | HEEpiC | esophagus: | n/a |
24 | chr3:195724401-195724451 | T-47D | breast: | n/a |
25 | chr3:195724401-195724451 | ProgFib | skin: | n/a |
26 | chr3:195723614-195723664 | PFSK-1 | brain: | n/a |
27 | chr3:195723614-195723664 | RPTEC | kidney: | n/a |
28 | chr3:195724371-195724421 | PANC-1 | pancreas: | n/a |
29 | chr3:195724401-195724451 | CMK | blood: | n/a |
30 | chr3:195724371-195724421 | NB4 | blood: | n/a |
31 | chr3:195723614-195723664 | K562 | blood: | n/a |
32 | chr3:195724371-195724421 | IMR90 | lung: | fetal |
33 | chr3:195723614-195723664 | PrEC | prostate: | n/a |
34 | chr3:195724401-195724451 | GM12892 | blood: | n/a |
35 | chr3:195723614-195723664 | AG09319 | gingival: | n/a |
36 | chr3:195724371-195724421 | GM06990 | blood: | n/a |
37 | chr3:195724371-195724421 | HRE | kidney: | n/a |
38 | chr3:195724371-195724421 | RPTEC | kidney: | n/a |
39 | chr3:195724401-195724451 | Hepatocyte | liver: | n/a |
40 | chr3:195723614-195723664 | MCF-7 | breast: | n/a |
41 | chr3:195724371-195724421 | SK-N-MC | brain: | n/a |
42 | chr3:195723614-195723664 | H1-hESC | embryonic stem cell: | embryo |
43 | chr3:195724401-195724451 | AG04450 | lung: | fetal |
44 | chr3:195724371-195724421 | GM12891 | blood: | n/a |
45 | chr3:195724371-195724421 | PFSK-1 | brain: | n/a |
46 | chr3:195723614-195723664 | HL-60 | blood: | n/a |
47 | chr3:195723614-195723664 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr3:195724401-195724451 | HMEC | breast: | n/a |
49 | chr3:195723614-195723664 | Hela-S3 | cervix: | n/a |
50 | chr3:195723614-195723664 | T-47D | breast: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195586120..195586802-chr3:195721315..195721912,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TFRC-1 | chr3:195726007-195726255 | NONHSAT094273 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SDHAP1 | TF binding region |
ENSG00000231464 | TF binding region |
SDHAP1 | CpG island |
ENSG00000231464 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79368819 | chr3:195720855-195720856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565741713 | chr3:195720857-195720858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77007721 | chr3:195720864-195720865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2343855 | chr3:195720874-195720875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539661631 | chr3:195720876-195720877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542902011 | chr3:195720889-195720890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs57653434 | chr3:195720893-195720894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569893632 | chr3:195720929-195720930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11712922 | chr3:195720932-195720933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144598321 | chr3:195720935-195720936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11711384 | chr3:195720942-195720943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201302169 | chr3:195720945-195720946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199686129 | chr3:195720965-195720966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368553487 | chr3:195720987-195720988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555633393 | chr3:195721012-195721013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62283425 | chr3:195721013-195721014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370202190 | chr3:195721035-195721036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111979130 | chr3:195721036-195721037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375932285 | chr3:195721065-195721066 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs371544413 | chr3:195721163-195721164 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs375345470 | chr3:195721184-195721185 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs573708553 | chr3:195721206-195721207 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs4639005 | chr3:195721207-195721208 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs377247286 | chr3:195721228-195721229 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs4374560 | chr3:195721232-195721233 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs534972473 | chr3:195721236-195721237 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs62283426 | chr3:195721254-195721255 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs79208480 | chr3:195721269-195721270 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs369729912 | chr3:195721296-195721297 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs200884480 | chr3:195721297-195721298 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs200926534 | chr3:195721299-195721300 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs73208036 | chr3:195721300-195721301 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs368302696 | chr3:195721306-195721307 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs545147490 | chr3:195721307-195721308 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs77128281 | chr3:195721318-195721319 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs564317125 | chr3:195721321-195721322 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs74360404 | chr3:195721362-195721363 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs543748941 | chr3:195721373-195721374 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs28802010 | chr3:195721378-195721379 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs372568770 | chr3:195721387-195721388 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs559070890 | chr3:195721388-195721389 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs533076218 | chr3:195721403-195721404 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs140664026 | chr3:195721404-195721405 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs545308398 | chr3:195721415-195721416 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs111383581 | chr3:195721427-195721428 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs2638913 | chr3:195721464-195721465 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs62283427 | chr3:195721467-195721468 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs549271201 | chr3:195721473-195721474 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs567912317 | chr3:195721544-195721545 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs28852142 | chr3:195721570-195721571 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:195717800-195721200 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr3:195718000-195721200 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
3 | chr3:195720400-195726200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr3:195721000-195721400 | Enhancers | Primary T cells fromperipheralblood | blood |
5 | chr3:195721200-195721400 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
6 | chr3:195721200-195721400 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr3:195721400-195721800 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr3:195721800-195722200 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr3:195726200-195726400 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |